Pages that link to "Q24676028"
Jump to navigation
Jump to search
The following pages link to Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis (Q24676028):
Displaying 50 items.
- Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences (Q26747210) (← links)
- Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases (Q26825799) (← links)
- Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis (Q30426239) (← links)
- Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders (Q33608581) (← links)
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice (Q33608587) (← links)
- Genetic variation and clinical heterogeneity in cystic fibrosis (Q33645546) (← links)
- Pathology of gastrointestinal organs in a porcine model of cystic fibrosis (Q33703755) (← links)
- Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. (Q33869527) (← links)
- A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis (Q33880999) (← links)
- Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results (Q33926291) (← links)
- Identifying modifier genes of monogenic disease: strategies and difficulties. (Q34025944) (← links)
- Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. (Q34090196) (← links)
- Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis. (Q34205956) (← links)
- Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC. (Q34617453) (← links)
- Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis (Q34827581) (← links)
- Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease (Q35114878) (← links)
- Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. (Q35178642) (← links)
- Meconium ileus caused by mutations in GUCY2C, encoding the CFTR-activating guanylate cyclase 2C (Q36036566) (← links)
- A Joint Location-Scale Test Improves Power to Detect Associated SNPs, Gene Sets, and Pathways (Q36066687) (← links)
- Genetic modifiers of nutritional status in cystic fibrosis (Q36398331) (← links)
- Gene modifiers in cystic fibrosis (Q36470683) (← links)
- The influence of genetics on cystic fibrosis phenotypes (Q36526522) (← links)
- New animal models of cystic fibrosis: what are they teaching us? (Q36679834) (← links)
- Update in cystic fibrosis 2006 (Q36779226) (← links)
- Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway (Q36877047) (← links)
- Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs (Q36891023) (← links)
- Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis (Q36929794) (← links)
- Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs (Q36944556) (← links)
- The cystic fibrosis intestine (Q37122355) (← links)
- Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis (Q37193199) (← links)
- Genetic modifiers of cystic fibrosis-related diabetes (Q37193385) (← links)
- Update on gene modifiers in cystic fibrosis (Q37277637) (← links)
- Modifier genes in Mendelian disorders: the example of cystic fibrosis (Q37822861) (← links)
- Intestinal Obstruction Syndromes in Cystic Fibrosis: Meconium Ileus, Distal Intestinal Obstruction Syndrome, and Constipation (Q37850707) (← links)
- Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients (Q37887180) (← links)
- Longitudinal cystic fibrosis care (Q38059628) (← links)
- Disease-modifying genes and monogenic disorders: experience in cystic fibrosis (Q38233032) (← links)
- Cystic fibrosis genetics: from molecular understanding to clinical application (Q38268916) (← links)
- Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications (Q38317967) (← links)
- Cystic fibrosis from the gastroenterologist's perspective (Q38704228) (← links)
- Gastrointestinal surgery in adult patients with cystic fibrosis (Q39545550) (← links)
- Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation (Q39591725) (← links)
- High ambient temperature and risk of intestinal obstruction in cystic fibrosis. (Q39795035) (← links)
- Data that empower: The success and promise of CF patient registries. (Q40041155) (← links)
- Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene (Q41659539) (← links)
- Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities (Q44314873) (← links)
- Guanylate cyclase 2C agonism corrects CFTR mutants (Q49598448) (← links)
- Gastrointestinal Manifestations of Cystic Fibrosis. (Q53627194) (← links)
- Kcnn4 is a modifier gene of intestinal cystic fibrosis preventing lethality in the Cftr-F508del mouse. (Q55396999) (← links)
- Cystic fibrosis (Q55881299) (← links)